Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
06/12/1997 | WO1997020941A1 Constructs and methods for enhancing protein levels in photosynthetic organisms |
06/12/1997 | WO1997020938A2 Cells with hybrid receptor and gene construct which can be controlled by said hybrid receptor, and use of said cells in gene therapy |
06/12/1997 | WO1997020937A2 Modification process |
06/12/1997 | WO1997020936A1 Modification of starch synthesis in plants |
06/12/1997 | WO1997020935A2 Viral vectors |
06/12/1997 | WO1997020932A1 Specific binding members for human carcinoembryonic antigen, materials and methods |
06/12/1997 | WO1997020931A1 Method and compositions for monitoring dna binding molecules in living cells |
06/12/1997 | WO1997020927A1 Compounds having lectin properties and biological uses thereof |
06/12/1997 | WO1997020926A1 Il-13 receptor polypeptide |
06/12/1997 | WO1997020858A1 Apoptosis induced by monoclonal antibody anti-her2 |
06/12/1997 | WO1997020569A2 Bioartificial devices and cellular matrices therefor |
06/12/1997 | WO1997015655A3 New artificial tissue, method for the production and the use thereof |
06/12/1997 | WO1997012972A3 Regulated genes and uses thereof |
06/12/1997 | WO1997012035A3 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
06/12/1997 | CA2770851A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
06/12/1997 | CA2239951A1 Method and compositions for monitoring dna binding molecules in living cells |
06/12/1997 | CA2239305A1 Constructs and methods for enhancing protein levels in photosynthetic organisms |
06/12/1997 | CA2238981A1 Viral vectors |
06/12/1997 | CA2238893A1 Il-13 receptor polypeptide |
06/12/1997 | CA2238399A1 Modification of starch synthesis in plants |
06/12/1997 | CA2237495A1 Compounds having lectin properties and biological uses thereof |
06/12/1997 | CA2236913A1 Apoptosis induced by monoclonal antibody anti-her2 |
06/11/1997 | EP0778347A2 ATP and nucleic acid-binding protein with putative helicase and ATPase characteristics |
06/11/1997 | EP0777736A1 Functional modified hsv1-tk |
06/11/1997 | EP0777732A1 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
06/11/1997 | EP0777729A1 5-lipoxygenase-activating protein ii |
06/11/1997 | EP0777728A1 Polycystic kidney disease 1 gene and uses thereof |
06/11/1997 | EP0777689A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells |
06/11/1997 | EP0777688A1 New immunocontraceptive peptides |
06/11/1997 | EP0777684A1 Calcitonin receptor |
06/11/1997 | EP0777497A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
06/11/1997 | EP0777493A1 Calcitonin gene related peptide receptor |
06/11/1997 | EP0446315B1 Process for the preparation of pai-2 |
06/11/1997 | EP0394409B1 Macrophage-derived inflammatory mediator (mip-2) |
06/11/1997 | CN2255982Y Extractor of cloned cell |
06/11/1997 | CN1151760A Serum paraoxonase |
06/11/1997 | CN1151759A Antibodies which bind to insect jut proteins and their use |
06/11/1997 | CN1151758A Novel growth of differentiation factor of the TGF- 'beta' family |
06/10/1997 | US5637785 Genetically modified plants having modulated flower development |
06/10/1997 | US5637686 Tata-binding protein associated factor, nucleic acids |
06/10/1997 | US5637493 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |
06/10/1997 | US5637492 Activatable fibrinolytic and anti-thrombotic proteins |
06/10/1997 | US5637486 Methods of identifying potentially therapeutically effective agents and cell strains for use therein |
06/10/1997 | US5637484 Culturing tissues or cells of plant belonging to genus taxus in presence of jasmonic acid, recovering taxane |
06/10/1997 | US5637481 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
06/10/1997 | US5637472 Hydrazine derivatized cells |
06/10/1997 | US5637470 Screening array using cells expressing recombinant α and β subunits of the mammalian large-conductance (maxi-K) potassium channel |
06/10/1997 | US5637323 Administering interleukin |
06/10/1997 | US5637300 Contraceptive vaccine comprising a glycosylated 55 kD zona pellucida protein immunogen and method of use of the same in contraception |
06/05/1997 | WO1997020063A1 THEREAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8 |
06/05/1997 | WO1997020060A1 Conditionally replicating viral vectors and their use |
06/05/1997 | WO1997020059A1 Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis |
06/05/1997 | WO1997020056A2 Enhancer-increased gene expression in plants |
06/05/1997 | WO1997020051A2 Vectors and methods for gene transfer to cells |
06/05/1997 | WO1997020040A1 Starch branching enzyme ii of potato |
06/05/1997 | WO1997020035A1 Establishment, maintenance, and transfection of totipotent embryonic stem cells from the embryos of domestic animals |
06/05/1997 | WO1997020034A1 Auxinic analogues of indole-3-acetic acid |
06/05/1997 | WO1997019952A1 The ob receptor and methods of diagnosing and treating weight |
06/05/1997 | WO1997019950A1 Topiramate immunoassay, as well as analogs and antibodies |
06/05/1997 | WO1997019695A1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
06/05/1997 | WO1997010851A3 Nucleic acid delivery vehicle |
06/05/1997 | WO1997010334A3 Ribozyme therapy for the treatment and/or prevention of restenosis |
06/05/1997 | WO1996039530A3 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof |
06/05/1997 | CA2238569A1 The ob receptor and methods of diagnosing and treating weight |
06/05/1997 | CA2236868A1 Conditionally replicating viral vectors and their use |
06/05/1997 | CA2235962A1 Use of anti-sense sequences to increase responsiveness to gene amplification |
06/04/1997 | EP0776973A1 Fatty aldehyde decarbonylase for transforming bacterial cells and plants |
06/04/1997 | EP0776968A1 Liquid medium for nerve cells, process for producing the same and method for incubating nerve cells with the use of the same |
06/04/1997 | EP0776368A2 Protein toxins active against lepidopteran pests |
06/04/1997 | EP0776365A2 Retinoblastoma protein-interacting zinc finger proteins |
06/04/1997 | EP0776364A1 Glutamate receptor |
06/04/1997 | EP0776361A1 Recombinant herpesvirus of turkeys and uses thereof |
06/04/1997 | EP0776360A1 Dual fiber bioreactor |
06/04/1997 | EP0776359A1 Regulated apoptosis |
06/04/1997 | EP0776339A1 Mhc complexes and uses thereof |
06/04/1997 | EP0776337A1 Growth differentiation factor-11 |
06/04/1997 | EP0776335A1 Regulatable elimination of gene expression, gene product function and engineered host cells |
06/04/1997 | EP0776327A1 New multimerizing agents |
06/04/1997 | EP0776161A1 A method of selectively destroying neoplastic cells |
06/04/1997 | EP0690911A4 Stromelysin-1 deficient transgenic mice |
06/04/1997 | EP0681614A4 Isolation of fetal erythrocytes. |
06/04/1997 | EP0672119A4 Retroviral mediated transfer of the human multiple drug resistance gene. |
06/04/1997 | EP0411018B1 Detection, quantitation and classification of ras proteins in body fluids and tissues |
06/04/1997 | CN1151186A Thymidine kinase mutants |
06/04/1997 | CN1151183A RPS 2 gene and uses thereof |
06/04/1997 | CN1151167A Isolated MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
06/03/1997 | US5635618 Expression construct conferring root specific expresssion in plants comprising regulatory sequence of maize alpha-tubulin consisting of specified nucleotides |
06/03/1997 | US5635601 Beta-8 integrin subunit antibodies |
06/03/1997 | US5635493 Methods and compositions for poly-β-1-4-N-acetylglucosamine chemotherapeutics |
06/03/1997 | US5635482 Synthetic compounds and compositions with enhanced cell binding |
06/03/1997 | US5635399 Retroviral vectors expressing cytokines |
06/03/1997 | US5635388 Monoclonal antibody produced by a hybridoma cell binds to the extracellular domain of flk2/flk3 and activates the intracellular tyrosine kinase domain enhancing repopulation of myeloid and lymphoid blood cell lineages with cytokines |
06/03/1997 | US5635387 Methods and device for culturing human hematopoietic cells and their precursors |
06/03/1997 | US5635386 Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture |
06/03/1997 | US5635382 Method for enhancing transmembrane transport of exogenous molecules |
06/03/1997 | US5635376 Method for purifying chromosomes and hybrid muntjac cell lines containing foreign chromosomes |
06/03/1997 | US5635372 BMP-15 compositions |
06/03/1997 | US5635368 Bioreactor with immobilized lactic acid bacteria and the use thereof |
06/03/1997 | US5635359 Method for measuring the activity of angiotensin converting enzyme in biological samples |
06/03/1997 | US5635345 Isolation of lymphocytes, incubation with labeled monoclonal antibody to a prosomal protein, measuring percentage of cells having this protein on cell surface, comparison with non-infected cells, human immunodeficiency virus, kits |